Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells

被引：39

作者：

Maher, John ^{[1
,2
,3
]}

Wilkie, Scott ^{[1
]}

Davies, David M. ^{[1
]}

Arif, Sefina ^{[4
]}

Picco, Gianfranco ^{[1
]}

Julien, Sylvain ^{[5
]}

Foster, Julie ^{[6
]}

Burchell, Joy ^{[1
]}

Taylor-Papadimitriou, Joyce ^{[1
]}

机构：

[1] Kings Coll London, Guys Hosp, Div Canc Studies, London SE1 9RT, England

[2] Kings Coll Hosp NHS Fdn Trust, Dept Clin Immunol & Allergy, Denmark Hill, London SE5 9RS, England

[3] Eastbourne Hosp, Dept Immunol, Kings Dr, Eastbourne BN21 2UD, E Sussex, England

[4] Kings Coll London, Dept Immunobiol, London SE1 9RT, England

[5] Univ Lille, F-59650 Villeneuve Dascq, France

[6] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England

来源：

IMMUNITY | 2016年 / 45卷 / 05期

关键词：

CHIMERIC ANTIGEN RECEPTOR; CANCER;

D O I：

10.1016/j.immuni.2016.10.014

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：945 / 946

页数：2

共 7 条

[1] Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer [J].

Blidner, Ada G. ;

Marino, Karina V. ;

Rabinovich, Gabriel A. .

IMMUNITY, 2016, 44 (06) :1248-1250

[2]

BURCHELL J, 1987, CANCER RES, V47, P5476

[3] Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia [J].

Imai, C ;

Mihara, K ;

Andreansky, M ;

Nicholson, IC ;

Pui, CH ;

Geiger, TL ;

Campana, D .

LEUKEMIA, 2004, 18 (04) :676-684

[4] Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma [J].

Posey, Avery D., Jr. ;

Schwab, Robert D. ;

Boesteanu, Alina C. ;

Steentoft, Catharina ;

Mandel, Ulla ;

Engels, Boris ;

Stone, Jennifer D. ;

Madsen, Thomas D. ;

Schreiber, Karin ;

Haines, Kathleen M. ;

Cogdill, Alexandria P. ;

Chen, Taylor J. ;

Song, Decheng ;

Scholler, John ;

Kranz, David M. ;

Feldman, Michael D. ;

Young, Regina ;

Keith, Brian ;

Schreiber, Hans ;

Clausen, Henrik ;

Johnson, Laura A. ;

June, Carl H. .

IMMUNITY, 2016, 44 (06) :1444-1454

[5] Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity? [J].

van der Stegen, Sjoukje J. C. ;

Davies, David M. ;

Wilkie, Scott ;

Foster, Julie ;

Sosabowski, Jane K. ;

Burnet, Jerome ;

Whilding, Lynsey M. ;

Petrovic, Roseanna M. ;

Ghaem-Maghami, Sadaf ;

Mather, Stephen ;

Jeannon, Jean-Pierre ;

Parente-Pereira, Ana C. ;

Maher, John .

JOURNAL OF IMMUNOLOGY, 2013, 191 (09) :4589-4598

[6] Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer [J].

van Schalkwyk, May C. I. ;

Papa, Sophie E. ;

Jeannon, Jean-Pierre ;

Urbano, Teresa Guerrero ;

Spicer, James F. ;

Maher, John .

HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2013, 24 (03) :134-142

[7] Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor [J].

Wilkie, Scott ;

Picco, Gianfranco ;

Foster, Julie ;

Davies, David M. ;

Julien, Sylvain ;

Cooper, Lucienne ;

Arif, Sefina ;

Mather, Stephen J. ;

Taylor-Papadimitriou, Joyce ;

Burchell, Joy M. ;

Maher, John .

JOURNAL OF IMMUNOLOGY, 2008, 180 (07) :4901-4909

← 1 →